tivantinib (ARQ 197) / Merck (MSD), Kyowa Kirin, Daiichi Sankyo  >>  Phase 1
Welcome,         Profile    Billing    Logout  

0 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
No trials found

Download Options